Cargando…

N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized controlled trials (RCTs) in order to explore better subtypes of CCB for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Mingming, Zhang, Ziyan, Pan, Zhiyu, Ma, Sijia, Chang, Meiying, Fan, Jiao, Xue, Shunxuan, Wang, Yuejun, Qu, Hua, Zhang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053533/ https://www.ncbi.nlm.nih.gov/pubmed/36986438 http://dx.doi.org/10.3390/ph16030338

Ejemplares similares

Analysis of Ferroptosis-Related Gene Expression and Prognostic Factors of Renal Clear Cell Carcinoma Based on TCGA Database
por: Ma, Sijia, et al.
Publicado: (2021)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials
por: Zhao, Mingming, et al.
Publicado: (2021)

Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels
por: Wang, Dan, et al.
Publicado: (2022)

Sex Differences in the Anti-Hypertensive Effect of Calcium-Channel Blockers: A Systematic Review and Meta-Analysis
por: van Luik, Eveline M., et al.
Publicado: (2023)

Calcium channel blocker in patients with chronic kidney disease
por: Ohno, Shoko, et al.
Publicado: (2021)

Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
por: Zhao, Mingming, et al.
Publicado: (2021)

L-type calcium channel blockers, morphine and pain: Newer insights
por: Kumar, Rakesh, et al.
Publicado: (2010)

Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers
por: Wang, Dan, et al.
Publicado: (2018)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker
por: Chou, Tz-Chong
Publicado: (2014)

Characterization of Novel Cannabinoid Based T-Type Calcium Channel Blockers with Analgesic Effects
por: Bladen, Chris, et al.
Publicado: (2014)

Aging Reduces L-Type Calcium Channel Current and the Vasodilatory Response of Small Mesenteric Arteries to Calcium Channel Blockers
por: Albarwani, Sulayma A., et al.
Publicado: (2016)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
por: Nishida, Yayoi, et al.
Publicado: (2012)

Development of phenotypic assays for identifying novel blockers of L-type calcium channels in neurons
por: Hagan, Rebecca, et al.
Publicado: (2021)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta‐analysis
por: Liang, Ling, et al.
Publicado: (2022)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
por: Gandhi, Tamanna, et al.
Publicado: (2016)

Conceptual DFT, QTAIM, and Molecular Docking Approaches to Characterize the T-Type Calcium Channel Blocker Anandamide
por: Rangel-Galván, Maricruz, et al.
Publicado: (2022)

L-type calcium channel blocker increases VEGF concentrations in retinal cells and human serum
por: Kumar, Anmol, et al.
Publicado: (2023)

Effects of T-Type Calcium Channel Blockers on Renal Function and Aldosterone in Patients with Hypertension: A Systematic Review and Meta-Analysis
por: Li, Xue, et al.
Publicado: (2014)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

Calcium Channel Blocker-induced Gingival Overgrowth
por: Matsuura, Hiroki, et al.
Publicado: (2018)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Are calcium channel blockers related to lung cancer?
por: Rattanathanoo, Ratchanon, et al.
Publicado: (2023)

Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension
por: Shiga, Yuhei, et al.
Publicado: (2017)

The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers
por: Fukuda, Michio, et al.
Publicado: (2019)

Comparative analysis of mouse skeletal muscle fibre type composition and contractile responses to calcium channel blocker
por: Mänttäri, Satu, et al.
Publicado: (2005)

Discovery of novel L-type voltage-gated calcium channel blockers and application for the prevention of inflammation and angiogenesis
por: Saddala, Madhu Sudhana, et al.
Publicado: (2020)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
por: Kawabata, Yutaka, et al.
Publicado: (2020)

Statin, Calcium Channel Blocker and Beta Blocker Therapy May Decrease the Incidence of Tuberculosis Infection in Elderly Taiwanese Patients with Type 2 Diabetes
por: Lee, Mei-Yueh, et al.
Publicado: (2015)

T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease
por: Abe, Masanori, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_369vkc868mhmgejriep2gjic3q